News | May 28, 2025
Fluor-built Bayer cell therapy facility in California achieves LEED v4 platinum certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Investment demonstrates confidence in America’s commitment to science and innovation
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Awards highlight Avantor's commitment to the Biopharma industry
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Subscribe To Our Newsletter & Stay Updated
